---
figid: PMC7646947__MMR-22-06-4967-g00
figlink: pmc/articles/PMC7646947/figure/f1-mmr-22-06-4967/
number: F1
caption: Molecules and signaling pathways involved in muscle protein synthesis and
  degradation. Under physiological conditions, IGF-1 activates AKT through a PI3K-dependent
  process, leading to the activation of mTOR and thus resulting in the increased proliferation
  of muscle cells and increased protein synthesis in muscle cells. IL-6 and TNF-α
  are considered to be the main mediators of the inflammation in muscle atrophy caused
  by cancer cachexia. The binding of IL-6 to its receptor induces AMPK and STAT3 expression.
  STAT3 induces the activation of the IKK/NF-κB pathway and caspase-3 and C/EBPδ expression,
  which activates the UPS, causing muscle protein degradation. AMPK is a downstream
  target of IL-6 signaling, which inhibits the mTOR cascade, and activates the UPS.
  Physiologically, AKT inhibits FOXO, which promotes protein synthesis. In cancer
  cachexia, FOXO inhibits MyoD and activates the UPS, thereby promoting protein degradation.
  Moreover, the activation of NF-κB due to the degradation of the IκB inhibitor by
  IKK is TNF-α-dependent. The NF-κB pathway can further activate the UPS to cause
  muscle protein degradation. TNF-α can also induce the p38 MAPK pathway, which activates
  the UPS. IGF-1, insulin-like growth factor 1; AMPK, AMP-activated protein kinase;
  IKK, IκB kinase; C/EBPδ, CCAAT/enhancer-binding protein δ; UPS, ubiquitin-proteasome
  system; MyoD, myoblast determination protein 1; R, receptor.
pmcid: PMC7646947
papertitle: Molecular mechanisms of cancer cachexia-induced muscle atrophy.
reftext: Wei Yang, et al. Mol Med Rep. 2020 Dec;22(6):4967-4980.
pmc_ranked_result_index: '3119'
pathway_score: 0.969421
filename: MMR-22-06-4967-g00.jpg
figtitle: Molecules and signaling pathways involved in muscle protein synthesis and
  degradation
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- herbal medicine
- Corydalis turtschaninovii
- Drosophila melanogaster
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7646947__MMR-22-06-4967-g00.html
  '@type': Dataset
  description: Molecules and signaling pathways involved in muscle protein synthesis
    and degradation. Under physiological conditions, IGF-1 activates AKT through a
    PI3K-dependent process, leading to the activation of mTOR and thus resulting in
    the increased proliferation of muscle cells and increased protein synthesis in
    muscle cells. IL-6 and TNF-α are considered to be the main mediators of the inflammation
    in muscle atrophy caused by cancer cachexia. The binding of IL-6 to its receptor
    induces AMPK and STAT3 expression. STAT3 induces the activation of the IKK/NF-κB
    pathway and caspase-3 and C/EBPδ expression, which activates the UPS, causing
    muscle protein degradation. AMPK is a downstream target of IL-6 signaling, which
    inhibits the mTOR cascade, and activates the UPS. Physiologically, AKT inhibits
    FOXO, which promotes protein synthesis. In cancer cachexia, FOXO inhibits MyoD
    and activates the UPS, thereby promoting protein degradation. Moreover, the activation
    of NF-κB due to the degradation of the IκB inhibitor by IKK is TNF-α-dependent.
    The NF-κB pathway can further activate the UPS to cause muscle protein degradation.
    TNF-α can also induce the p38 MAPK pathway, which activates the UPS. IGF-1, insulin-like
    growth factor 1; AMPK, AMP-activated protein kinase; IKK, IκB kinase; C/EBPδ,
    CCAAT/enhancer-binding protein δ; UPS, ubiquitin-proteasome system; MyoD, myoblast
    determination protein 1; R, receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - TNF
  - IGF1
  - IL6R
  - TNFRSF1A
  - IGF1R
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK3
  - MAPK8
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - FOXO6
  - FOXO1
  - FOXO3
  - FOXO4
  - STAT3
  - CHUK
  - IKBKG
  - IKBKB
  - AKT2
  - AKT3
  - AKT1
  - MYOD1
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - MTOR
  - HMBS
genes:
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: TNF-aR
  symbol: TNFAR
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: АКT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: (MyoD
  symbol: MYOD
  source: hgnc_alias_symbol
  hgnc_symbol: MYOD1
  entrez: '4654'
- word: (NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: (NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: (NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: (NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: (NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: UPS
  symbol: UPS
  source: hgnc_prev_symbol
  hgnc_symbol: HMBS
  entrez: '3145'
chemicals: []
diseases: []
figid_alias: PMC7646947__F1
redirect_from: /figures/PMC7646947__F1
figtype: Figure
---
